Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$2.66 USD
-0.11 (-3.97%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $2.66 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Earnings News For EDIT
-
Editas Q3 Loss Narrower Than Expected, Revenues Decrease Y/Y
-
Editas Medicine (EDIT) Reports Q3 Loss, Misses Revenue Estimates
-
Earnings Preview: Editas Medicine (EDIT) Q3 Earnings Expected to Decline
-
Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
-
Editas (EDIT) Q2 Earnings & Revenues Miss Estimates, Stock Down
-
Editas: Q2 Earnings Snapshot
-
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates
-
Editas (EDIT) Down 2.3% Since Last Earnings Report: Can It Rebound?
-
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
-
Editas: Q1 Earnings Snapshot
-
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
-
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
-
Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?
-
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
-
Editas: Q4 Earnings Snapshot
-
Editas: Q4 Earnings Snapshot
-
Editas (EDIT) Q3 Earnings & Revenues Beat, Pipeline in Focus
-
Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates
-
Editas: Q3 Earnings Snapshot
-
Why Is Editas (EDIT) Down 4.3% Since Last Earnings Report?
-
Editas' (EDIT) Q2 Earnings Beat, Sales Miss, Pipeline in Focus
-
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates
-
Editas: Q2 Earnings Snapshot
-
Editas (EDIT) Q1 Earnings Top, Pipeline in Focus, Stock Up
-
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates